Skip to main content

Table 4 Multiple variable analysis of risk differences for in-hospital mortality among matched patients with Acinetobacter baumannii pneumonia

From: Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis

Variable

Adjusted risk differences % [95% CI]

p-value

Colistin vs. tigecycline

-16.4 [-0.9 to - 31.8]

.04

Propensity score

-30.3 [-85.0 to - 24.3]

.28

Age

0.3 [-0.07 to - 0.6]

.11

Male

-11.8 [-29.5 to - 5.9]

.19

Carbapenem combination

-20.8 [-45.8 to - 4.2]

.10